Performance of bleeding risk scores in dialysis patients

被引:33
|
作者
Ocak, Gurbey [1 ]
Ramspek, Chava [2 ]
Roolunaaker, Maarten B. [1 ]
Blankestijn, Peter J. [1 ]
Verhaar, Marianne C. [1 ]
Bos, Willem Jan W. [3 ]
Dekker, Friedo W. [2 ]
van Diepen, Merel [2 ]
机构
[1] Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands
[2] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands
[3] St Antonius Hosp, Dept Internal Med, Nieuwegein, Netherlands
关键词
ATRIA; dialysis; HASBLED; HEMORR2HAGES; ORBIT; HAS-BLED SCORE; ATRIAL-FIBRILLATION; ANTICOAGULATED PATIENTS; HEMODIALYSIS-PATIENTS; CHA(2)DS(2)-VASC SCORES; MULTIPLE IMPUTATION; WARFARIN INITIATION; PREDICTIVE ABILITY; ISCHEMIC-STROKE; HEMORRHAGE;
D O I
10.1093/ndt/gfy387
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background Bleeding risk scores have been created to identify patients with an increased bleeding risk, which could also be useful in dialysis patients. However, the predictive performances of these bleeding risk scores in dialysis patients are unknown. Therefore, the aim of this study was to validate existing bleeding risk scores in dialysis patients. Methods A cohort of 1745 incident dialysis patients was prospectively followed for 3 years during which bleeding events were registered. We evaluated the discriminative performance of the Hypertension, Abnormal kidney and liver function, Stroke, Bleeding, Labile INR, Elderly and Drugs or alcohol (HASBLED), the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA), the Hepatic or kidney disease, Ethanol abuse, Malignancy, Older age, Reduced platelet count or Reduced platelet function, Hypertension, Anaemia, Genetic factors, Excessive fall risk and Stroke (HEMORR2HAGES) and the Outcomes Registry for Better Informed Treatment (ORBIT) bleeding risk scores by calculating C-statistics with 95% confidence intervals (CI). In addition, calibration was evaluated by comparing predicted and observed risks. Results Of the 1745 dialysis patients, 183 patients had a bleeding event, corresponding to an incidence rate of 5.23/100 person-years. The HASBLED [C-statistic of 0.58 (95% CI 0.54-0.62)], ATRIA [C-statistic of 0.55 (95% CI 0.51-0.60)], HEMORR2HAGES [C-statistic of 0.56 (95% CI 0.52-0.61)] and ORBIT [C-statistic of 0.56 (95% CI 0.52-0.61)] risk scores had poor discriminative performances in dialysis patients. Furthermore, the calibration analyses showed that patients with a low risk of bleeding according to the HASBLED, ATRIA, HEMORR2HAGES and ORBIT bleeding risk scores had higher incidence rates for bleeding in our cohort than predicted. Conclusions The HASBLED, ATRIA, HEMORR2HAGES and ORBIT bleeding risk scores had poor predictive abilities in dialysis patients. Therefore, these bleeding risk scores may not be useful in this population.
引用
收藏
页码:1223 / 1231
页数:9
相关论文
共 50 条
  • [1] Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis
    Shah, Mitesh
    Tsadok, Meytal Avgil
    Jackevicius, Cynthia A.
    Essebag, Vidal
    Eisenberg, Mark J.
    Rahme, Elham
    Humphries, Karin H.
    Tu, Jack V.
    Behlouli, Hassan
    Guo, Helen
    Pilote, Louise
    CIRCULATION, 2014, 129 (11) : 1196 - 1203
  • [2] Performance of the HAS-BLED, ORBIT, and ATRIA Bleeding Risk Scores on a Cohort of 399 344 Hospitalized Patients With Atrial Fibrillation and Cancer: Data From the French National Hospital Discharge Database
    Pastori, Daniele
    Marang, Amelie
    Bisson, Arnaud
    Herbert, Julien
    Lip, Gregory Yoke Hong
    Fauchier, Laurent
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (23):
  • [3] Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry
    Esteve-Pastor, Maria A.
    Rivera-Caravaca, Jose M.
    Roldan, Vanessa
    Sanmartin Fernandez, Marcelo
    Arribas, Fernando
    Masjuan, Jaime
    Barrios, Vivencio
    Cosin-Sales, Juan
    Freixa-Pamias, Roman
    Recalde, Esther
    Perez-Cabeza, Alejandro, I
    Vazquez Rodriguez, Jose Manuel
    Priu, Carles Rafols
    Anguita Sanchez, Manuel
    Lip, Gregory Y. H.
    Marin, Francisco
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 9 (01) : 38 - 46
  • [4] Comparison of bleeding risk scores and evaluation of major bleeding predictive factors in patients with major bleeding due to vitamin K antagonist use
    Yildirim, Sinan
    Aslan, Onur
    HELIYON, 2023, 9 (08)
  • [5] Bleeding risk of haemodialysis and peritoneal dialysis patients
    van der Sluijs, Anita van Eck
    Abrahams, Alferso C.
    Rookmaaker, Maarten B.
    Verhaar, Marianne C.
    Bos, Willem Jan W.
    Blankestijn, Peter J.
    Dekker, Friedo W.
    van Diepen, Merel
    Ocak, Gurbey
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (01) : 170 - 175
  • [6] Risk scores for major bleeding from direct oral anticoagulants: comparing predictive performance in patients with atrial fibrillation
    Campos-Staffico, Alessandra M.
    Jacoby, Juliet P.
    Dorsch, Michael P.
    Limdi, Nita A.
    Barnes, Geoffrey D.
    Luzum, Jasmine A.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (01)
  • [7] Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation
    Apostolakis, Stavros
    Lane, Deirdre A.
    Guo, Yutao
    Buller, Harry
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (09) : 861 - 867
  • [8] Validation of Bleeding Risk Prediction Scores for Patients With Major Bleeding on Direct Oral Anticoagulants
    Tchen, Stephanie
    Ryba, Nicole
    Patel, Vishal
    Cavanaugh, Joseph
    Sullivan, Jesse B.
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (12) : 1175 - 1184
  • [9] Modified HASBLED Bleeding Risk Score in Dialysis Patients With Atrial Fibrillation
    Murphy, Michele
    Maddox, William
    Nahman, Stan
    Diamond, Matthew
    Sorrentino, Robert
    Guha, Avirup
    Waller, Jennifer
    CIRCULATION, 2015, 132
  • [10] Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial
    Proietti, M.
    Hijazi, Z.
    Andersson, U.
    Connolly, S. J.
    Eikelboom, J. W.
    Ezekowitz, M. D.
    Lane, D. A.
    Oldgren, J.
    Roldan, V.
    Yusuf, S.
    Wallentin, L.
    JOURNAL OF INTERNAL MEDICINE, 2018, 283 (03) : 282 - 292